Do negative or positive emotions differentially impact mortality after adult stem cell transplant?

Bone Marrow Transplantation

Volumn 38, Issue 4, 2006, Pages 255-264

  Hoodin, F ^a   Uberti, J P ^b   Lynch, T J ^a   Steele, P ^c   Ratanatharathorn, V ^b  

^a EASTERN MICHIGAN UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; RECOMBINANT CYTOKINE;

BEHAVIOR DISORDER; CLINICAL TRIAL; DATA ANALYSIS; DEPRESSION; EMOTION; EXPECTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; METHODOLOGY; MORTALITY; MULTIVARIATE ANALYSIS; OPTIMISM; POPULATION RESEARCH; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PUBLICATION; REVIEW; RISK FACTOR; SAMPLE SIZE; SOCIAL PSYCHOLOGY; SURVIVAL; SURVIVAL TIME; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; BEHAVIORAL SYMPTOMS; EMOTIONS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; TREATMENT OUTCOME;

EID: 33747003803     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705419     Document Type: Review

References (54)

1. Appelbaum FR. The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer. CA Cancer J Clin 1996; 46: 142-164.
2. Hoodin F, Weber S. A systematic review of psychosocial factors affecting survival after bone marrow transplantation. Psychosomatics 2003; 44: 181-195.
3. Petticrew M, Bell R, Hunter D. Influence of psychological coping on survival and recurrence in people with cancer: Systematic review. BMJ 2002; 325: 1066.
4. Beck AT, Steer RA, Brown GK. BDI-II Manual: Beck Depression Inventory, 2nd edn. The Psychological Corporation: San Antonio, TX, 1996.
5. Chang G, Orav EJ, Tong M, Antin JH. Predictors of 1-year survival assessed at the time of bone marrow transplantation. Psychosomatics 2004; 45: 378-385.
6. Broers S, Hengeveld MW, Kaptein AA, Le Cessie S, van de Loo F, de Vries T. Are pretransplant psychological variables related to survival after bone marrow transplantation? A prospective study of 123 consecutive patients. J Psychosom Res 1998; 45: 341-351.
7. Andrykowski MA, Brady MJ, Henslee-Downey PJ. Psychosocial factors predictive of survival after allogeneic bone marrow transplantation for leukemia. Psychosom Med 1994; 56: 432-439.
8. Jenkins PL, Lester H, Alexander J, Whittaker J. A prospective study of psychosocial morbidity in adult bone marrow transplant recipients. Psychosomatics 1994; 35: 361-367.
9. Murphy KC, Jenkins PL, Whittaker JA. Psychosocial morbidity and survival in adult bone marrow transplant recipients - a follow-up study. Bone Marrow Transplant 1996; 18: 199-201.
10. Hoffman LH, Szkrumelak N, Sullivan AK. Psychiatric assessment of candidates for bone marrow transplantation: A psychodynamically-oriented approach. Int J Psychiatry Med 1999; 29: 13-28.
11. Sullivan AK, Szkrumelak N, Hoffman LH. Psychological risk factors and early complications after bone marrow transplantation in adults. Bone Marrow Transplant 1999; 24: 1109-1120.
12. Neuser J. Personality and survival time after bone marrow transplantation. J Psychosom Res 1988; 32: 451-455.
13. Chang G, Antin JH, Orav EJ, Randall U, McGarigle C, Behr HM. Substance abuse and bone marrow transplant. Am J Drug Alcohol Abuse 1997; 23: 301-308.
14. Prieto JM, Atala J, Blanch J, Carreras E, Rovira M, Cirera E et al. Role of depression as a predictor of mortality among cancer patients after stem-cell transplantation. J Clin Oncol 2005; 23: 6063-6071.
15. Frick E, Motzke C, Fischer N, Busch R, Bumeder I. Is perceived social support a predictor of survival for patients undergoing autologous peripheral blood stem cell transplantation? Psycho-oncology 2005; 14: 759-770.
16. Hoodin F, Kalbfleisch KR, Thornton J, Ratanatharathorn V. Psychosocial influences on 305 adults' survival after bone marrow transplantation; depression, smoking, and behavioral self-regulation. J Psychosom Res 2004; 57: 145-154.
17. Lee SJ, Loberiza FR, Rizzo JD, Soiffer RJ, Antin JH, Weeks JC. Optimistic expectations and survival after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2003; 9: 389-396.
18. Loberiza Jr FR, Rizzo JD, Bredeson CN, Antin JH, Horowitz MM, Weeks JC et al. Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol 2002; 20: 2118-2126.
19. Akaho R, Sasaki T, Mori S, Akiyama H, Yoshino M, Hagiya K et al. Psychological factors and survival after bone marrow transplantation in patients with leukemia. Psychiatry Clin Neurosci 2003; 57: 91-96.
20. Tschuschke V, Hertenstein B, Arnold R, Bunjes D, Denzinger R, Kaechele H. Associations between coping and survival time of adult leukemia patients receiving allogeneic bone marrow transplantation: Results of a prospective study. J Psychosom Res 2001; 50: 277-285.
21. Molassiotis A, van den Akker OB, Boughton BJ. Perceived social support, family environment and psychosocial recovery in bone marrow transplant long-term survivors. Soc Sci Med 1997; 44: 317-325.
22. Rodrigue JR, Pearman TP, Moreb J. Morbidity and mortality following bone marrow transplantation: Predictive utility of pre-BMT affective functioning, compliance, and social support stability. Int J Behav Med 1999; 6: 241-254.
23. Colon EA, Callies AL, Popkin MK, McGlave PB. Depressed mood and other variables related to bone marrow transplantation survival in acute leukemia. Psychosomatics 1991; 32: 420-425.
24. American Psychiatric Association. Diagnostic and Statistics Manual of Mental Disorders, 4th edn. American Psychiatric Association: Washington, DC, 1994.
25. McNair P, Lorr M, Droppelman L. POMS Manual, 2nd edn. Educational and Industrial Testing Service: San Diego, CA, 1981.
26. Hathaway SR, McKinley JC. The Minnesota Multiphasic Personality Inventory Manual for Administration and Scoring. University of Minnesota Press: Minneapolis, MN, 1983.
27. Wittchen HU, Robins LN, Cottler LB, Sartorius N, Burke JD, Regier D. Cross-cultural feasibility, reliability and sources of variance of the Composite International Diagnostic Interview (CIDI). The Multicentre WHO/ ADAMHA Field Trials. Br J Psychiatry 1991; 159: 645-653, 658.
28. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370.
29. Koeter J, Ormel J. General Health Questionnaire-Nederlandse bewerking. Swets & Zeitlinger: Handleiding, Lisse, 1991.
30. Capuron L, Dantzer R. Cytokines and depression: The need for a new paradigm. Brain Behav Immun 2003; 17 (Suppl 1): S119-S124.
31. Jalowiec A, Murphy SP, Powers MJ. Psychometric assessment of the Jalowiec Coping Scale. Nurs Res 1984; 33: 157-161.
32. Watson M, Greer S, Young J, Inayat Q, Burgess C, Robertson B. Development of a questionnaire measure of adjustment to cancer: The MAC scale. Psychol Med 1988; 18: 203-209.
33. Syrjala KL, Langer SL, Abrams JR, Storer B, Sanders JE, Flowers ME et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA 2004; 291: 2335-2343.
34. Herrman C, Brand-Driehorst S, Kaminsky B, Leibing E, Staats H, Ruger U. Diagnostic groups and depressed mood as predictors of 22-month mortality in medical inpatients. Psychosom Med 1998; 60: 570-577.
35. Penninx BW, Leveille S, Ferrucci L, van Eijk JT, Guralnik JM. Exploring the effect of depression on physical disability: Longitudinal evidence from the established populations for epidemiologic studies of the elderly. Am J Public Health 1999; 89: 1346-1352.
36. Kiecolt-Glaser JK, Glaser R. Methodological issues in behavioral immunology research with humans. Brain Behav Immun 1988; 2: 67-78.
37. Kiecolt-Glaser JK, Glaser R. Depression and immune function: Central pathways to morbidity and mortality. J Psychosom Res 2002; 53: 873-876.
38. Kiecolt-Glaser JK, Glaser R, Gravenstein S, Malarkey WB, Sheridan J. Chronic stress alters the immune response to influenza virus vaccine in older adults. Proc Natl Acad Sci USA 1996; 93: 3043-3047.
39. Glaser R, Kiecolt-Glaser JK, Bonneau RH, Malarkey W, Kennedy S, Hughes J. Stress-induced modulation of the immune response to recombinant hepatitis B vaccine. Psychosom Med 1992; 54: 22-29.
40. Glaser R, Sheridan J, Malarkey WB, MacCallum RC, Kiecolt-Glaser JK. Chronic stress modulates the immune response to a pneumococcal pneumonia vaccine. Psychosom Med 2000; 62: 804-807.
41. Vedhara K, Cox NK, Wilcock GK, Perks P, Hunt M, Anderson S et al. Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination. Lancet 1999; 353: 627-631.
42. Burns EA, Lum LG, Seigneuret MC, Giddings BR, Goodwin JS. Decreased specific antibody synthesis in old adults: Decreased potency of antigen-specific B cells with aging. Mech Ageing Dev 1990; 53: 229-241.
43. Knight S. Oncology and hematology. In: Camic P, Knight S (eds). Clinical Handbook of Health Psychology: A Practical Guide to Effective Interventions, 2nd edn. Hogrefe & Huber: Seattle, WA, 2004.
44. Cohen-Cole S, Brown F, McDaniel J. Assessment of depression and grief reactions in the medically ill. In: Stoudemire A, Fogel B (eds). Psychiatric Care of the Medical Patient. Oxford University Press: New York, NY, 1993, pp. 53-69.
45. Radloff LS. The CES-D Scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 386-401.
46. Scheier MF, Carver CS, Bridges MW. Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): A reevaluation of the Life Orientation Test. J Pers Soc Psychol 1994; 67: 1063-1078.
47. Carver CS, Smith RG, Antoni MH, Petronis VM, Weiss S, Derhagopian RP. Optimistic personality and psychosocial well-being during treatment predict psychosocial well-being among long-term survivors of breast cancer. Health Psychol 2005; 24: 508-516.
48. Spiegel D, Giese-Davis J. Depression and cancer: Mechanisms and disease progression. Biol Psychiatry 2003; 54: 269-282.
49. Trijsburg RW, van Knippenberg FC, Rijpma SE. Effects of psychological treatment on cancer patients: A critical review. Psychosom Med 1992; 54: 489-517.
50. Antoni MH, Lehman JM, Kilbourn KM, Boyers AE, Culver JL, Alferi SM et al. Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychol 2001; 20: 20-32.
51. Beck JS. Cognitive Therapy: Basics and Beyond. Guilford Press: New York, NY, 1995.
52. Lee SJ, Loberiza FR, Antin JH, Kirkpatrick T, Prokop L, Alyea EP et al. Routine screening for psychosocial distress following hematopoietic stem cell transplantation. Bone Marrow Transplant 2005; 35: 77-83.
53. Kuchler T, Henne-Bruns D, Rappat S, Graul J, Holst K, Williams JI et al. Impact of psychotherapeutic support on gastrointestinal cancer patients undergoing surgery: Survival results of a trial. Hepatogastroenterology 1999; 46: 322-335.
54. Trask PC, Jones D, Paterson AG. Minimal contact intervention with autologous BMT patients: Impact on QOL and emotional distress. J Clin Psychol Medl Settings 2003; 10: 109-117.